Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-19T05:09:14.715Z Has data issue: false hasContentIssue false

Chapter 25 - The Development of Ovarian Stimulation for In-Vitro Fertilization

Published online by Cambridge University Press:  09 June 2018

By
Colin M. Howles
Edited by
Gabor Kovacs ,
Peter Brinsden  and
Alan DeCherney
Gabor Kovacs
Affiliation:
Monash University, Victoria
Peter Brinsden
Affiliation:
Bourn Hall Clinic, Cambridge
Alan DeCherney
Affiliation:
National Institutes of Health, Bethesda
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
In-Vitro Fertilization
The Pioneers' History
 , pp. 202 - 207
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aboulghar, MA, Mansour, RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275–289.CrossRefGoogle ScholarPubMed
Boostanfar, R, Mannaerts, B, Pang, S, et al. A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. Fertil Steril 2012; 97: 1351–1358.CrossRefGoogle ScholarPubMed
Cobo, A, Garrido, N, Pellicer, A, Remohí, J. Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril 2015; 104: 1426–1434.CrossRefGoogle ScholarPubMed
Devroey, P, Polyzos, NP, Blockeel, C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011; 26: 2593–2597.CrossRefGoogle ScholarPubMed
Dosouto, C, Haahr, T, Humaidan, P. Gonadotropin-releasing hormone agonist (GnRHa) trigger – State of the art. Reprod Biol 2017; 17: 1–8.CrossRefGoogle ScholarPubMed
Edwards, RG. The history of assisted human conception with especial reference to endocrinology. Exp Clin Endocrinol Diabetes 1996; 104: 183–204.CrossRefGoogle ScholarPubMed
Edwards, RG, Steptoe, PC. Current status of in-vitro fertilisation and implantation of human embryos. Lancet 1983 (Dec. 3); 2(8362): 1265–1269.Google Scholar
Edwards, RG, Steptoe, PC, Purdy, JM. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980; 87: 737–756.CrossRefGoogle ScholarPubMed
Edwards, RG, Fishel, SB, Cohen, J, et al. Factors influencing the success of in vitro fertilization for alleviating human infertility. J In Vitro Fert Embryo Transf 1984; 1: 3–23.Google Scholar
Fauser, BC, Diedrich, K, Devroey, P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008; 14: 1–14.CrossRefGoogle ScholarPubMed
Fauser, BC, Mannaerts, BM, Devroey, P, et al. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update 2009; 15: 309–321.CrossRefGoogle ScholarPubMed
Fishel, SB, Edwards, RG, Walters, DE. Follicular steroids as a prognosticator of successful fertilization of human oocytes in vitro. J Endocrinol 1983 (Nov); 99(2): 335–344.Google Scholar
Fishel, SB, Edwards, RG, Purdy, JM, et al. Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin. J In Vitro Fert Embryo Transf 1985; 2: 123–131.Google Scholar
Fleming, R, Adam, AH, Barlow, DH, et al. A new systematic treatment for infertile women with abnormal hormone profiles. Br J Obstet Gynaecol 1982; 89: 80–83.Google Scholar
Glasier, A, Thatcher, SS, Wickings, EJ, et al. Superovulation with exogenous gonadotrophins does not inhibit the luteinizing hormone surge. Fertil Steril 1988; 49: 81.CrossRefGoogle Scholar
Hillier, SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994; 9: 188–191.CrossRefGoogle ScholarPubMed
Hillier, SG. IVF endocrinology: the Edwards era. Mol Hum Reprod 2013 (Dec.); 19(12): 799–808.CrossRefGoogle ScholarPubMed
Howles, CM. Genetic engineering of human FSH (Gonal-F). Hum Reprod Update 1996; 2: 172–191.Google Scholar
Howles, CM. Recombinant gonadotrophins in reproductive medicine: the gold standard of today. Reprod Biomed Online 2006; 12: 11–13.CrossRefGoogle ScholarPubMed
Howles, CM, Macnamee, MC. The endocrinology of stimulated cycles and influence on outcome. In: Mashiach, S et al. (eds.) Advances in Assisted Reproductive Technologies. New York Plenum Press, 1990, p. 311.CrossRefGoogle Scholar
Howles, CM, Macnamee, MC, Edwards, RG, Goswamy, R, Steptoe, PC. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 1986; 2(8505): 521–522.Google Scholar
Howles, CM, Macnamee, MC, Edwards, RG. Follicular development and early luteal function of conception and non conceptional cycles after human in vitro fertilisation: endocrine correlates. Hum Reprod 1987; 2: 17.Google Scholar
Howles, CM, Macnamee, MC, Edwards, RG. Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme. Hum Reprod 1987 (Nov); 2(8): 655–656.CrossRefGoogle ScholarPubMed
Humaidan, P, Bredkjaer, HE, Bungum, L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005; 20: 1213–1220.CrossRefGoogle ScholarPubMed
Humaidan, P, Engmann, L, Benadiva, C. Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril 2015; 103: 879–885.CrossRefGoogle ScholarPubMed
Jones, WJ Jr., Jones, GS, Andrews, MC, et al. The program for in vitro fertilization at Norfolk. Fertil Steril 1982; 38: 14–21.CrossRefGoogle ScholarPubMed
Kol, S, Muchtar, M. Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research. Reprod Biomed Online 2005; 10: 575–577.CrossRefGoogle ScholarPubMed
Loumaye, E, Martineau, I, Piazzi, A, et al. Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum Reprod 1996; 11 Suppl. 1: 95–107.CrossRefGoogle ScholarPubMed
Lunenfeld, B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update 2004; 10: 453–467.CrossRefGoogle ScholarPubMed
Macnamee, MC, Edwards, RG, Howles, CM. The influence of stimulation regimens and luteal phase support on the outcome of IVF. Hum Reprod 1988; 3 (suppl. 2): 43.CrossRefGoogle Scholar
Macnamee, MC, Howles, CM, Edwards, RG. Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists. Hum Reprod 1987 (Oct.); 2(7): 569–571.CrossRefGoogle ScholarPubMed
Messinis, IE, Templeton, AA, Baird, DT. Endogenous LH surge during superovulation induction with sequential use of cc and pulsatile HMG. J Clin Endocrinol Metab 1985; 61: 1076.Google Scholar
Nyboe Andersen, A, Nelson, SM, Fauser, BC, et al. ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril 2017; 107: 387–396.Google Scholar
Porter, RN, Smith, W, Craft, IL, Abdulwahid, NA, Jacobs, HS. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; 2(8414): 1284–1285.Google Scholar
Rettenbacher, M, Andersen, AN, Garcia-Velasco, JA, et al. A multi-centre phase 3 study comparing efficacy and safety of Bemfola(®) versus Gonal-f(®) in women undergoing ovarian stimulation for IVF. Reprod Biomed Online 2015; 30: 504–513.CrossRefGoogle ScholarPubMed
Steptoe, PC, Edwards, RG. Laparoscopic recovery of preovulatory human oocytes after priming of ovaries with gonadotrophins. Lancet 1970; 1(7649): 683–689.Google Scholar
Steptoe, PC, Edwards, RG Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet 1976; 1(7965): 880–882.CrossRefGoogle ScholarPubMed
Trounson, AO, Leeton, JF, Wood, C, Webb, J, Wood, J. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981; 212: 681–682.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×